FinancialsNonlife Insurance
  • Price (EUR)40.19
  • Today's Change0.22 / 0.55%
  • Shares traded574.58k
  • 1 Year change+45.04%
  • Beta1.3485
Data delayed at least 15 minutes, as of Oct 15 2021 16:35 BST.
More ▼
Take Action
Take Action
Add this security to watchlist, portfolio, or create an alert to track market movement

Events & Activity

  • ASRNL:AEX price reached a new 52-week high of 40.49 at 13:31 BST
  • ASRNL:AEX price moved over -1.09% to 40.01
  • ASRNL:AEX price falls below 15-day moving average to 39.53 at 10:52 BST
  • ASRNL:AEX price falls below 15-day moving average to 39.45 at 16:52 BST

Key statistics

On Friday, ASR Nederland NV (ASRNL:AEX) closed at 40.19, -0.89% below its 52-week high of 40.55, set on Oct 15, 2021.
52-week range
25.33Oct 29 202040.55Oct 15 2021
Markit short selling activity
Previous close40.19
Average volume506.45k
Shares outstanding138.06m
Free float137.30m
P/E (TTM)7.55
Market cap5.55bn EUR
EPS (TTM)5.32
Annual div (ADY)2.70
Annual div yield (ADY)6.72%
Div ex-dateAug 30 2021
Div pay-dateSep 03 2021
Data delayed at least 15 minutes, as of Oct 15 2021 16:35 BST.
More ▼
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
Markit Short Selling Activity © Markit. All rights reserved.
Although Markit has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of Markit on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.